SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001267602-23-000083 from ALIMERA SCIENCES INC (ALIM) (CIK 0001267602)

ALIMERA SCIENCES INC (ALIM) (CIK 0001267602)
Date: July 10, 2023 · CIK: 0001267602 · Accession: 0001267602-23-000083

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-273090

Date
July 10, 2023
Author

Form
CORRESP
Company
ALIMERA SCIENCES INC (ALIM) (CIK 0001267602)

Letter

20230710 accel

Alimera Sciences, Inc.

6310 Town Square, Suite 400

Alpharetta, GA 30005

July 10, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street N.E.

Washington, D.C. 20549

Attn:

Cindy Polynice

Re:

Alimera Sciences, Inc.

Registration Statement on Form S-3 (File No. 333-273090)

Ladies and Gentlemen:

Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, Alimera Sciences, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission take appropriate action to make the above-referenced Registration Statement on Form S-3 effective at 4:00 p.m. Eastern Time on Wednesday, July 12, 2023 or as soon thereafter as practicable.

The Company hereby authorizes Keith J. Scherer of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.

Once the Registration Statement has been declared effective, the Company requests that it be notified by a telephone call to Mr. Scherer at 617 648 9231.

Thank you for your attention on this matter.



Very truly yours,


Show Raw Text
CORRESP
1
filename1.htm

			20230710 accel

			Alimera Sciences, Inc.

			6310 Town Square, Suite 400

			Alpharetta, GA 30005

			July 10, 2023

			VIA EDGAR

			Securities and Exchange Commission

			Division of Corporation Finance

			100 F Street N.E.

			Washington, D.C. 20549

						Attn:

						Cindy Polynice

						Re:

						Alimera Sciences, Inc.

			Registration Statement on Form S-3 (File No. 333-273090)

			Ladies and Gentlemen:

			Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, Alimera Sciences, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission take appropriate action to make the above-referenced Registration Statement on Form S-3 effective at 4:00 p.m. Eastern Time on Wednesday, July 12, 2023 or as soon thereafter as practicable.

			The Company hereby authorizes Keith J. Scherer of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.

			Once the Registration Statement has been declared effective, the Company requests that it be notified by a telephone call to Mr. Scherer at 617 648 9231.

			Thank you for your attention on this matter.

						

						Very truly yours,

						

						Alimera Sciences, Inc.

						

						By:

						/s/ Christopher S. Visick

						

						Christopher S. Visick

						

						General Counsel and Secretary

						cc:

						Keith J. Scherer, Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP